Answers are grounded in this paper and cite their sources.
The establishment of preoperative chemotherapy (PCT) with FOLFIRINOX and gemcitabine/nab-paclitaxel in recent years has enabled resectability in many patients with initially locally advanced pancreatic cancer (LAPC). Nevertheless, information about the impact of PCT on surgical results is scarce.
No takes yet. Share an insight, caveat, or question.
Petrikowski et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: